Related Experiment Video
Updated: Jun 23, 2026

07:27
The Murine Choline-Deficient, Ethionine-Supplemented (CDE) Diet Model of Chronic Liver Injury
Published on: October 21, 2017
Hepatic microsomal function in rats with chronic dietary iron overload
Gastroenterology
|June 1, 1986
Summary
Chronic dietary iron overload in rats causes liver damage, leading to lipid peroxidation and reduced cytochrome P450 enzyme activity. This study shows iron accumulation impairs hepatic microsomal function.
Area of Science:
- Biochemistry
- Toxicology
- Hepatology
Background:
- Hepatic microsomal function is crucial for detoxification and metabolism.
- Iron overload can lead to oxidative stress and cellular damage.
- Understanding the impact of iron on liver enzymes is vital for managing iron-related diseases.
Purpose of the Study:
- To investigate the effects of chronic dietary iron overload on hepatic microsomal function in rats.
- To determine if iron-induced lipid peroxidation is associated with alterations in key liver enzymes.
Main Methods:
- Rats were fed diets with varying carbonyl iron concentrations for different durations.
- Hepatic iron concentrations, microsomal conjugated diene formation (lipid peroxidation marker), and concentrations of cytochrome P450, cytochrome b5, and enzyme activities (aminopyrine demethylase, glucose-6-phosphatase) were measured.
Main Results:
- High hepatic iron concentrations (above 4090 µg/g) induced significant microsomal lipid peroxidation.
- Iron overload led to significant decreases in cytochrome P450 concentration (35-56%) and aminopyrine demethylase activity (16%).
- Cytochrome b5 levels also decreased (28%), while heme oxygenase activity increased (47%) in one group.
Conclusions:
- Oral iron loading can induce in vivo microsomal lipid peroxidation in the liver.
- This peroxidation is linked to selective reductions in microsomal hemoprotein concentrations and cytochrome P450-dependent enzymes.
- The findings highlight the detrimental effects of iron overload on hepatic microsomal integrity and function.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...

